Olema Pharmaceuticals (OLMA) Files $200M Mixed Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St futures gain on tech rebound, Middle East peace hopes
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil falls as traders digest escalation in US-Iran strikes
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
- UBS sees generational semiconductor boom, highlights stock winners
Form S-3 Olema Pharmaceuticals,
January 6, 2025 4:07 PM ESTTable of Contents
As filed with the Securities and Exchange Commission on January 6, 2025
Registration No. 333-
... More
Form S-3 Olema Pharmaceuticals,
January 3, 2025 4:50 PM ESTTable of Contents
As filed with the Securities and Exchange Commission on January 3, 2025
Registration No. 333-
UNITED... More
